Adenosine receptors and Parkinson's disease:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego, CA
Academic Press
c2000
|
| Schriftenreihe: | Pure and applied mathematics (Academic Press)
60 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (xviii, 275 p. [1] col. plate) |
| ISBN: | 9780124004054 0124004059 9781435605138 1435605136 0080525954 9780080525952 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV042307106 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s2000 |||| o||u| ||||||eng d | ||
| 020 | |a 9780124004054 |9 978-0-12-400405-4 | ||
| 020 | |a 0124004059 |9 0-12-400405-9 | ||
| 020 | |a 9781435605138 |c electronic bk. |9 978-1-4356-0513-8 | ||
| 020 | |a 1435605136 |c electronic bk. |9 1-4356-0513-6 | ||
| 020 | |a 0080525954 |9 0-08-052595-4 | ||
| 020 | |a 9780080525952 |9 978-0-08-052595-2 | ||
| 035 | |a (OCoLC)162574424 | ||
| 035 | |a (DE-599)BVBBV042307106 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 616.8/33 |2 22 | |
| 245 | 1 | 0 | |a Adenosine receptors and Parkinson's disease |c edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner |
| 264 | 1 | |a San Diego, CA |b Academic Press |c c2000 | |
| 300 | |a 1 Online-Ressource (xviii, 275 p. [1] col. plate) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pure and applied mathematics (Academic Press) |v 60 | |
| 500 | |a This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Parkinson Disease / drug therapy | |
| 650 | 4 | |a Receptors, Purinergic P1 / antagonists & inhibitors | |
| 650 | 4 | |a Adenosine | |
| 650 | 4 | |a Parkinson's disease / Treatment | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Alzheimer's & Dementia |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Neurology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Parkinson's disease | |
| 650 | 4 | |a Adenosine |x Receptors | |
| 650 | 4 | |a Adenosine |x Antagonists |x Therapeutic use | |
| 650 | 0 | 7 | |a Adenosinrezeptor |0 (DE-588)4327002-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 0 | 1 | |a Adenosinrezeptor |0 (DE-588)4327002-5 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Kase, Hiroshi |e Sonstige |4 oth | |
| 700 | 1 | |a Richardson, Peter J. |e Sonstige |4 oth | |
| 700 | 1 | |a Jenner, Peter |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780124004054 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FAW_PDA_ESD | |
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027744098 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804152892042510336 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042307106 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)162574424 (DE-599)BVBBV042307106 |
| dewey-full | 616.8/33 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/33 |
| dewey-search | 616.8/33 |
| dewey-sort | 3616.8 233 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03625nmm a2200649zcb4500</leader><controlfield tag="001">BV042307106</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780124004054</subfield><subfield code="9">978-0-12-400405-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0124004059</subfield><subfield code="9">0-12-400405-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781435605138</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-4356-0513-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1435605136</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-4356-0513-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080525954</subfield><subfield code="9">0-08-052595-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080525952</subfield><subfield code="9">978-0-08-052595-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)162574424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042307106</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/33</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adenosine receptors and Parkinson's disease</subfield><subfield code="c">edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego, CA</subfield><subfield code="b">Academic Press</subfield><subfield code="c">c2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xviii, 275 p. [1] col. plate)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pure and applied mathematics (Academic Press)</subfield><subfield code="v">60</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson Disease / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, Purinergic P1 / antagonists & inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adenosine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson's disease / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Alzheimer's & Dementia</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Neurology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson's disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adenosine</subfield><subfield code="x">Receptors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adenosine</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Adenosinrezeptor</subfield><subfield code="0">(DE-588)4327002-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Adenosinrezeptor</subfield><subfield code="0">(DE-588)4327002-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kase, Hiroshi</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Richardson, Peter J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jenner, Peter</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780124004054</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027744098</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV042307106 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:55Z |
| institution | BVB |
| isbn | 9780124004054 0124004059 9781435605138 1435605136 0080525954 9780080525952 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027744098 |
| oclc_num | 162574424 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (xviii, 275 p. [1] col. plate) |
| psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Academic Press |
| record_format | marc |
| series2 | Pure and applied mathematics (Academic Press) |
| spelling | Adenosine receptors and Parkinson's disease edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner San Diego, CA Academic Press c2000 1 Online-Ressource (xviii, 275 p. [1] col. plate) txt rdacontent c rdamedia cr rdacarrier Pure and applied mathematics (Academic Press) 60 This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints Includes bibliographical references and index Parkinson Disease / drug therapy Receptors, Purinergic P1 / antagonists & inhibitors Adenosine Parkinson's disease / Treatment HEALTH & FITNESS / Diseases / Alzheimer's & Dementia bisacsh MEDICAL / Neurology bisacsh Medizin Parkinson's disease Adenosine Receptors Adenosine Antagonists Therapeutic use Adenosinrezeptor (DE-588)4327002-5 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Parkinson-Krankheit (DE-588)4044683-9 s Adenosinrezeptor (DE-588)4327002-5 s 2\p DE-604 Kase, Hiroshi Sonstige oth Richardson, Peter J. Sonstige oth Jenner, Peter Sonstige oth http://www.sciencedirect.com/science/book/9780124004054 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Adenosine receptors and Parkinson's disease Parkinson Disease / drug therapy Receptors, Purinergic P1 / antagonists & inhibitors Adenosine Parkinson's disease / Treatment HEALTH & FITNESS / Diseases / Alzheimer's & Dementia bisacsh MEDICAL / Neurology bisacsh Medizin Parkinson's disease Adenosine Receptors Adenosine Antagonists Therapeutic use Adenosinrezeptor (DE-588)4327002-5 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| subject_GND | (DE-588)4327002-5 (DE-588)4044683-9 (DE-588)4143413-4 |
| title | Adenosine receptors and Parkinson's disease |
| title_auth | Adenosine receptors and Parkinson's disease |
| title_exact_search | Adenosine receptors and Parkinson's disease |
| title_full | Adenosine receptors and Parkinson's disease edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner |
| title_fullStr | Adenosine receptors and Parkinson's disease edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner |
| title_full_unstemmed | Adenosine receptors and Parkinson's disease edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner |
| title_short | Adenosine receptors and Parkinson's disease |
| title_sort | adenosine receptors and parkinson s disease |
| topic | Parkinson Disease / drug therapy Receptors, Purinergic P1 / antagonists & inhibitors Adenosine Parkinson's disease / Treatment HEALTH & FITNESS / Diseases / Alzheimer's & Dementia bisacsh MEDICAL / Neurology bisacsh Medizin Parkinson's disease Adenosine Receptors Adenosine Antagonists Therapeutic use Adenosinrezeptor (DE-588)4327002-5 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| topic_facet | Parkinson Disease / drug therapy Receptors, Purinergic P1 / antagonists & inhibitors Adenosine Parkinson's disease / Treatment HEALTH & FITNESS / Diseases / Alzheimer's & Dementia MEDICAL / Neurology Medizin Parkinson's disease Adenosine Receptors Adenosine Antagonists Therapeutic use Adenosinrezeptor Parkinson-Krankheit Aufsatzsammlung |
| url | http://www.sciencedirect.com/science/book/9780124004054 |
| work_keys_str_mv | AT kasehiroshi adenosinereceptorsandparkinsonsdisease AT richardsonpeterj adenosinereceptorsandparkinsonsdisease AT jennerpeter adenosinereceptorsandparkinsonsdisease |